Interleukin 1 blockade withcanakinumab for Hyper IGD syndrome (HIDS)

פריטים דומים

• Interleukin 1 blockade with canacinumab for hyperimmunoglobulin D and periodic fever syndrome
  מאת: Brunner, Juergen, et al.
  יצא לאור: (2014)
• Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study
  מאת: Aróstegui, JI, et al.
  יצא לאור: (2015)
• Hiper IgD syndrome (HIDS): clinical and genetic features in five patients
  מאת: Marco, A, et al.
  יצא לאור: (2008)
• Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept
  מאת: ARKWRIGHT, P D, et al.
  יצא לאור: (2002)
• Hyper Immunoglobulin D syndrome (HIDS): understanding what it is like to live with this rare condition
  מאת: Dandekar, P, et al.
  יצא לאור: (2015)